$2.16 Billion is the total value of Deep Track Capital, LP's 55 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 107.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $154,962,500 | -11.8% | 1,250,000 | +4.2% | 7.17% | -0.5% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $113,203,200 | -18.1% | 7,370,000 | +19.9% | 5.24% | -7.7% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $92,987,526 | +16.5% | 3,546,435 | +14.4% | 4.30% | +31.3% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $84,726,983 | +36.0% | 6,557,816 | +3.3% | 3.92% | +53.3% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $73,386,000 | -19.4% | 4,050,000 | +18.3% | 3.40% | -9.1% |
| GH | New | GUARDANT HEALTH INC | $53,700,000 | – | 1,500,000 | +100.0% | 2.49% | – |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $50,200,393 | +28.2% | 2,778,107 | +21.9% | 2.32% | +44.5% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $42,061,900 | +9.9% | 1,317,316 | +5.4% | 1.95% | +23.9% |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $34,069,488 | +29.7% | 835,446 | +18.6% | 1.58% | +46.3% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $30,439,353 | -2.7% | 1,279,502 | +4.0% | 1.41% | +9.6% |
| EDIT | New | EDITAS MEDICINE INC | $28,424,313 | – | 3,453,744 | +100.0% | 1.32% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $28,124,010 | +4.6% | 2,499,912 | +7.1% | 1.30% | +17.8% |
| ANIP | New | ANI PHARMACEUTICALS INC | $27,669,750 | – | 514,021 | +100.0% | 1.28% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $27,608,612 | – | 384,200 | +100.0% | 1.28% | – |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $25,200,979 | +47.8% | 2,781,565 | +18.6% | 1.17% | +66.7% |
| New | ZURA BIO LTD | $20,688,600 | – | 2,523,000 | +100.0% | 0.96% | – | |
| RAPT | Buy | RAPT THERAPEUTICS INC | $18,785,291 | +79.2% | 1,004,561 | +75.9% | 0.87% | +101.9% |
| PRTA | New | PROTHENA CORP PLCput | $17,070,000 | – | 250,000 | +100.0% | 0.79% | – |
| MORF | New | MORPHIC HLDG INC | $12,426,392 | – | 216,752 | +100.0% | 0.58% | – |
| ORTX | New | ORCHARD THERAPEUTICS PLCspon ads new | $10,637,101 | – | 2,041,670 | +100.0% | 0.49% | – |
| NKTR | Buy | NEKTAR THERAPEUTICS | $10,338,336 | +743.7% | 17,973,464 | +931.0% | 0.48% | +858.0% |
| TERN | New | TERNS PHARMACEUTICALS INC | $9,617,930 | – | 1,099,192 | +100.0% | 0.44% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $8,471,463 | – | 300,300 | +100.0% | 0.39% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $5,616,821 | – | 678,360 | +100.0% | 0.26% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $5,530,950 | – | 108,450 | +100.0% | 0.26% | – | |
| FGEN | New | FIBROGEN INCcall | $2,064,690 | – | 764,700 | +100.0% | 0.10% | – |
| New | MINK THERAPEUTICS INC | $682,221 | – | 324,867 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-09-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| SC 13G | 2024-05-10 |
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-26 |
| SC 13G/A | 2024-04-22 |
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.